These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 31711529)

  • 1. Long-term multidisciplinary integrative therapy management resulted in favorable outcomes for ovarian cancer during pregnancy: a case report and literature review.
    Xu T; Wang L; Jia Y; Jia Z; Li Z; Cui S; Cui M
    J Ovarian Res; 2019 Nov; 12(1):108. PubMed ID: 31711529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. When Less Is More: Minimally Invasive Surgery Compared with Laparotomy for Interval Debulking After Neoadjuvant Chemotherapy in Women with Advanced Ovarian Cancer.
    Brown J; Drury L; Crane EK; Anderson WE; Tait DL; Higgins RV; Naumann RW
    J Minim Invasive Gynecol; 2019; 26(5):902-909. PubMed ID: 30240899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-operative prediction of residual disease after interval cytoreduction for epithelial ovarian cancer using HE4.
    Lof P; van de Vrie R; Korse CM; van Driel WJ; van Gent MDJM; Karlsen MA; Amant F; Lok CAR
    Int J Gynecol Cancer; 2019 Oct; 29(8):1304-1310. PubMed ID: 31515411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety results from GEICO 1205, a randomized phase II trial of neoadjuvant chemotherapy with or without bevacizumab for advanced epithelial ovarian cancer.
    Garcia Garcia Y; de Juan Ferré A; Mendiola C; Barretina-Ginesta MP; Gaba Garcia L; Santaballa Bertrán A; Bover Barcelo I; Gil-Martin M; Manzano A; Rubio Pérez MJ; Romeo Marin M; Arqueros Núñez C; García-Martínez E; Gonzalez Martin A
    Int J Gynecol Cancer; 2019 Jul; 29(6):1050-1056. PubMed ID: 31263024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carboplatin chemotherapy in a pregnant patient with undifferentiated ovarian carcinoma: case report and review of the literature.
    Tabata T; Nishiura K; Tanida K; Kondo E; Okugawa T; Sagawa N
    Int J Gynecol Cancer; 2008; 18(1):181-4. PubMed ID: 17466045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morbidity after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy with carboplatin used for ovarian, tubal, and primary peritoneal cancer.
    Mikkelsen MS; Christiansen T; Petersen LK; Blaakaer J; Iversen LH
    J Surg Oncol; 2019 Sep; 120(3):550-557. PubMed ID: 31267569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant and post-surgical treatment in high-grade epithelial ovarian cancer.
    Wood GE; Ledermann JA
    Best Pract Res Clin Obstet Gynaecol; 2022 Jan; 78():64-73. PubMed ID: 34607745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in surgical complexity and treatment modalities utilized in the management of ovarian cancer in an era of neoadjuvant chemotherapy.
    Horner W; Peng K; Pleasant V; Brackmann M; Ebott J; Gutfreund R; McLean K; Reynolds RK; Uppal S
    Gynecol Oncol; 2019 Aug; 154(2):283-289. PubMed ID: 31196575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive value of the age-adjusted Charlston co-morbidity index on peri-operative complications, adjuvant chemotherapy usage and survival in patients undergoing debulking surgery after neo-adjuvant chemotherapy for advanced epithelial ovarian cancer.
    Phillips A; Singh K; Pounds R; Sundar S; Kehoe S; Nevin J; Elattar A; Balega J
    J Obstet Gynaecol; 2017 Nov; 37(8):1070-1075. PubMed ID: 28741395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced Ovarian Cancer: Weighing the Risks and Benefits of Surgery.
    Kumar A; Cliby WA
    Clin Obstet Gynecol; 2020 Mar; 63(1):74-79. PubMed ID: 31725415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant chemotherapy before definite operative approach for women with advanced-stage epithelial ovarian cancer.
    Wang PH
    Taiwan J Obstet Gynecol; 2018 Oct; 57(5):623-624. PubMed ID: 30342639
    [No Abstract]   [Full Text] [Related]  

  • 12. Using an evidence-based triage algorithm to reduce 90-day mortality after primary debulking surgery for advanced epithelial ovarian cancer.
    Narasimhulu DM; Kumar A; Weaver AL; McGree ME; Langstraat CL; Cliby WA
    Gynecol Oncol; 2019 Oct; 155(1):58-62. PubMed ID: 31402165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytoreductive surgery plus chemotherapy versus chemotherapy alone for recurrent epithelial ovarian cancer.
    Pappa C; Galaal K; Smyth S; Bristow RE; Khashan AS; Alazzam M
    Cochrane Database Syst Rev; 2024 Jun; 6(6):CD015297. PubMed ID: 38934360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor biology and impact on timing of surgery in advanced epithelial ovarian cancer.
    Tsibulak I; Fotopoulou C
    Int J Gynecol Cancer; 2023 Oct; 33(10):1627-1632. PubMed ID: 37553165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical complexity score and role of laparoscopy in women with advanced ovarian cancer treated with neoadjuvant chemotherapy.
    Davidson BA; Broadwater G; Crim A; Boccacio R; Bixel K; Backes F; Previs RA; Salinaro J; Salani R; Moore K; Secord AA
    Gynecol Oncol; 2019 Mar; 152(3):554-559. PubMed ID: 30558972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating the benefits of neoadjuvant chemotherapy for advanced epithelial ovarian cancer: a retrospective study.
    Gao Y; Li Y; Zhang C; Han J; Liang H; Zhang K; Guo H
    J Ovarian Res; 2019 Sep; 12(1):85. PubMed ID: 31519183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary debulking surgery vs. interval debulking surgery for advanced ovarian cancer: review of the literature and meta-analysis.
    Chiofalo B; Bruni S; Certelli C; Sperduti I; Baiocco E; Vizza E
    Minerva Med; 2019 Aug; 110(4):330-340. PubMed ID: 31081304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel classification of residual disease after interval debulking surgery for advanced-stage ovarian cancer to better distinguish oncologic outcome.
    Manning-Geist BL; Hicks-Courant K; Gockley AA; Clark RM; Del Carmen MG; Growdon WB; Horowitz NS; Berkowitz RS; Muto MG; Worley MJ
    Am J Obstet Gynecol; 2019 Oct; 221(4):326.e1-326.e7. PubMed ID: 31082382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of radical cytoreductive surgery on omission and delay of chemotherapy for advanced-stage ovarian cancer.
    Wright JD; Herzog TJ; Neugut AI; Burke WM; Lu YS; Lewin SN; Hershman DL
    Obstet Gynecol; 2012 Oct; 120(4):871-81. PubMed ID: 22996105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current Strategy for the Treatment of Ovarian Germ Cell Tumors: Role of Extensive Surgery.
    Li J; Wu X
    Curr Treat Options Oncol; 2016 Aug; 17(8):44. PubMed ID: 27357180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.